Home » Focus in ophthalmology » Drug development process
Ocular drug development

With 24 years of experience in ophthalmology, Iris Pharma is an internationally renowned Contract Research Organization (CRO) with unique experience and knowledge of all the stages involved in developing eye medication including preclinical formulation and research in vivo (proof-of concept, GLP studies, animal research models), Phase I to IV clinical studies, medico-marketing surveys, bioanalytical testing service and strategic consulting.

 

Iris Pharma
Preclinical formulation
Proof of concept
Ocular safety
Pharmacokinetics
Ocular efficacy
In vivo models (research)
Ocular histopathology
Bioanalytical testing
Project Management
Medical writing
Clinical Research Associates
Global drug development
Strategic consulting

 

 

For more details on a specific service in the drug development process, please click on the graph.